These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33460015)

  • 1. Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine.
    Lee JY; Glynn TR; Moskowitz JT; Fuchs D; Neilands TB; Dilworth SE; Feaster DJ; Rodriguez A; Carrico AW
    J Neurovirol; 2021 Feb; 27(1):178-182. PubMed ID: 33460015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intersecting minority statuses and tryptophan degradation among stimulant-using, sexual minority men living with HIV.
    Vincent W; Carrico AW; Dilworth SE; Fuchs D; Neilands TB; Moskowitz JT; Flentje A
    J Consult Clin Psychol; 2021 Mar; 89(3):156-165. PubMed ID: 33829804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    Chahine A; Koru-Sengul T; Feaster DJ; Dilworth SE; Antoni MH; Klatt N; Roach ME; Pallikkuth S; Sharkey M; Salinas J; Stevenson M; Pahwa S; Fuchs D; Carrico AW
    J Acquir Immune Defic Syndr; 2021 Mar; 86(3):353-360. PubMed ID: 33165125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
    Carrico AW; Neilands TB; Dilworth SE; Evans JL; Gόmez W; Jain JP; Gandhi M; Shoptaw S; Horvath KJ; Coffin L; Discepola MV; Andrews R; Woods WJ; Feaster DJ; Moskowitz JT
    J Int AIDS Soc; 2019 Dec; 22(12):e25436. PubMed ID: 31860172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autoregressive cross-lagged model unraveling co-occurring stimulant use and HIV: Results from a randomized controlled trial.
    Lee JY; Lee JE; Moskowitz JT; Feaster DJ; Neilands TB; Dilworth SE; Rodriguez A; Carrico AW
    Drug Alcohol Depend; 2021 Aug; 225():108752. PubMed ID: 34144507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-related drivers of sexual compulsivity and sexuality in sexual minority men who use methamphetamine.
    Kondur HR; Lee TK; McIntosh R; Gouse H; Paul R; Grov C; Fuchs D; Gómez W; Dilworth SE; Neilands TB; Carrico AW
    J Neurovirol; 2022 Jun; 28(3):446-455. PubMed ID: 35821194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of a positive affect intervention for methamphetamine users.
    Carrico AW; Gόmez W; Jain J; Shoptaw S; Discepola MV; Olem D; Lagana-Jackson J; Andrews R; Neilands TB; Dilworth SE; Evans JL; Woods WJ; Moskowitz JT
    Drug Alcohol Depend; 2018 Nov; 192():8-15. PubMed ID: 30195243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short circuit: Disaggregation of adrenocorticotropic hormone and cortisol levels in HIV-positive, methamphetamine-using men who have sex with men.
    Carrico AW; Rodriguez VJ; Jones DL; Kumar M
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29266420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive affect intervention alters leukocyte DNA methylation in sexual minority men with HIV who use methamphetamine.
    Carrico AW; Cherenack EM; Flentje A; Moskowitz JT; Asam K; Ghanooni D; Chavez JV; Neilands TB; Dilworth SE; Rubin LH; Gouse H; Fuchs D; Paul RH; Aouizerat BE
    Brain Behav Immun; 2024 Aug; 120():151-158. PubMed ID: 38777283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy.
    Carrico AW; Johnson MO; Morin SF; Remien RH; Riley ED; Hecht FM; Fuchs D
    Brain Behav Immun; 2008 Nov; 22(8):1257-62. PubMed ID: 18703133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minority Stress, Psychological Distress, Sexual Compulsivity, and Avoidance-Based Motivations Associated with Methamphetamine Use Among Sexual Minority Men Living with HIV: Examining Direct and Indirect Associations Using Cross-Sectional Structural Equation Modeling.
    Berlin GW; Dermody SS; Noor SW; Skakoon-Sparling S; Ghauri Y; Zahran A; Card KG; Lachowsky NJ; Cox J; Moore DM; Lambert G; Jollimore J; Grace D; Zhang H; Apelian H; Sang JM; Dvorakova M; Lal A; Hart TA
    Subst Use Misuse; 2024; 59(11):1629-1639. PubMed ID: 38950280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users.
    Carrico AW; Johnson MO; Colfax GN; Moskowitz JT
    AIDS Behav; 2010 Aug; 14(4):769-77. PubMed ID: 19125321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Crisis We Are Not Talking About: One-in-Three Annual HIV Seroconversions Among Sexual and Gender Minorities Were Persistent Methamphetamine Users.
    Grov C; Westmoreland D; Morrison C; Carrico AW; Nash D
    J Acquir Immune Defic Syndr; 2020 Nov; 85(3):272-279. PubMed ID: 32740370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users.
    Grosgebauer K; Salinas J; Sharkey M; Roach M; Pallikkuth S; Dilworth SE; Pahwa S; Koru-Sengul T; Stevenson M; Carrico AW
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):16-22. PubMed ID: 30046962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection.
    Vidot DC; Manuzak JA; Klatt NR; Pallikkuth S; Roach M; Dilworth SE; Pahwa S; Carrico AW
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):361-364. PubMed ID: 30958388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
    Lee J; Lee JY; Meade CS; Cohn M; Chahine A; Dilworth SE; Magidson JF; Gouse H; Fuchs D; Carrico AW
    J Neurovirol; 2020 Oct; 26(5):779-784. PubMed ID: 32728896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The familiar taste of poison": a qualitative study of multi-level motivations for stimulant use in sexual minority men living in South Florida.
    Davis-Ewart L; Lee JY; Viamonte M; Colon-Burgos J; Harkness A; Kanamori M; Duncan DT; Doblecki-Lewis S; Carrico AW; Grov C
    Harm Reduct J; 2023 Apr; 20(1):58. PubMed ID: 37101251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of text messages to reduce methamphetamine use and HIV sexual risk behaviors among men who have sex with men.
    Reback CJ; Fletcher JB; Leibowitz AA
    J Subst Abuse Treat; 2019 May; 100():59-63. PubMed ID: 30898329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of prescription stimulant misuse with subsequent methamphetamine use among a U.S. cohort of HIV-vulnerable sexual and gender minorities who have sex with men.
    Westmoreland DA; Goldshear JL; Carrico AW; Grov C
    Drug Alcohol Depend; 2021 Sep; 226():108841. PubMed ID: 34271513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual Minority Stress and Cellular Aging in Methamphetamine-Using Sexual Minority Men With Treated HIV.
    Ghanooni D; Carrico AW; Williams R; Glynn TR; Moskowitz JT; Pahwa S; Pallikkuth S; Roach ME; Dilworth S; Aouizerat BE; Flentje A
    Psychosom Med; 2022 Oct; 84(8):949-956. PubMed ID: 35980781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.